Epitalon: legal status and evidence

Short answer: Epitalon is not FDA-approved. Since October 30, 2026, a state-licensed pharmacy may compound Epitalon acetate for one patient with a prescription under an interim HHS policy, in these forms only: subcutaneous or intramuscular injection, given in intermittent courses [1], [2]. FDA’s own staff reviewed the evidence and recommended against it [2], [3].

At a glance

Legal status	HHS interim policy: compounding with a patient-specific prescription [1]
Form covered	Epitalon acetate [2]
Routes allowed	Subcutaneous or intramuscular injection, given in intermittent courses [2]
FDA Category 2	September 29, 2023 to April 22, 2026 [2]
FDA staff view	Recommended against adding it to the 503A bulks list [2], [3]
Advisory committee	Voted in favor [2]
Human evidence (FDA review)	No evidence it works for insomnia, and no clinical safety data in people. [3]
Last checked	November 5, 2026

What FDA’s staff found

FDA’s drug center (CDER) reviewed Epitalon for the uses it was nominated for: insomnia [3].

• FDA found a lack of evidence that Epitalon works for insomnia, the use it was nominated for. [3]
• It found no clinical data to support the safety of Epitalon in people, particularly by injection under the skin. [3]
• Animal studies were too limited in scope and length to judge safety. [3]

Why HHS allowed it anyway

HHS gave three reasons in Appendix B to its policy [2]:

1. Lots from FDA-registered facilities now report the endotoxin, microbial, residual solvent, solubility and elemental impurity results FDA’s review found missing;
2. Use in compounding is now documented and counted;
3. FDA’s safety concerns are based on how it might act rather than observed harm, the limited controlled human exposure reported no side effects, and documented use is in intermittent courses.

HHS may revisit the policy if a safety signal or a product quality problem appears, and the policy lasts until FDA decides in a final rule whether to add the peptide to the 503A bulks list [1].

How to get it legally

1. A licensed clinician decides it is right for you and writes a prescription in your name.
2. A state-licensed compounding pharmacy (503A) prepares it from an ingredient made at an FDA-registered facility, with a valid certificate of analysis [1].
3. The label says: “This is a compounded drug product. Not for resale.” It contains only one active ingredient [1].

See how to check a compounding pharmacy and how to read a peptide COA.

What is not known

FDA’s review found too little human data to describe how well Epitalon works or how safe it is over time [3]. Compounded drugs are not FDA-approved, which means FDA does not review their safety, effectiveness, or quality before they are marketed [1]. Talk to a licensed clinician before you use any compounded peptide.

Change log

• November 5, 2026: page created from the HHS policy, Appendix B and FDA’s July 2026 briefing document.